A concise synthetic pathway to the originally assigned structure of lyngbouilloside macrolactone (3) is reported. The core macrocycle 3 was synthesized via a phosphate tether-mediated, one-pot, sequential RCM/CM/chemoselective hydrogenation reaction, Roskamp homologation, and a high yielding Boeckman acylketene cyclization.
Lyngbouilloside has attracted significant attention from the synthetic community due to its stereochemical ambiguities, along with its biological activity and natural scarcity. 4, 5, 6 In 2008, Cossy and coworkers, reported the first stereoselective synthesis of the carbon backbone of 1 using a pivotal cross-metathesis (CM) between the C1-C8 and C9-C13 fragments. 4a In 2009, Ley and coworkers reported a synthesis of the lyngbouilloside macrolactone core using a late-stage ring-closing metathesis (RCM)/hydrogenation sequence for macrocyclization, and also brought to light stereochemical issues regarding this natural product. 4b In 2012, Cossy and coworkers confirmed the stereochemical issues in their first total synthesis of the lyngbouilloside aglycon using a pivotal acylketene macrolactonization of a tertiary methyl carbinol (C13 in 1) to circumvent fundamental issues associated with macrolactonizations of sterically encumbered alcohols. 5 In addition, Cossy proposed a revised structure of lyngbouilloside with stereochemical reassignment of the C11 stereogenic center having an epimeric C11 stereogenic center and thus a syn C10/C11 relationship. 5 In 2014, Fuwa and coworkers 7 completed an elegant total synthesis of (−)-lyngbyaloside B, employing innovative use of an Abiko-Masamune anti-aldol and a vinylogous Mukaiyama to install the requisite stereochemistry in the starting building blocks. In this work, synthetic, spectroscopic and molecular modeling studies provided unequivocal stereochemical reassignment of (−)-lyngbyaloside B having epimeric stereogenic centers at C10/C11 and C13 as shown for the reassigned lyngbyaloside B (2b) (Figure 1 ) when compared with the original assigned structure of lyngbyaloside B (2a). Moreover, the authors tested the titled compound and several derivatives and found good inhibition potencies against the proliferation of HL-60 cells. The authors also surmise that the structures of (−)-lyngbouilloside and the natural congeners of (−)-lyngbyaloside B be reconsidered accordingly. In this regard, confirmation of the complete stereostructure of 1 is still unknown, warranting continued effort for its total synthesis. Recently, we have engaged in the synthesis of biologically active natural products using phosphate tether-mediated approaches, 8, 9 and have developed a one-pot, sequential RCM/CM/chemoselective hydrogenation protocol mediated by a phosphate tether for the synthesis of advanced polyol and polyketide synthons. 8c Herein, we report application of a one-pot, sequential RCM/CM/ chemoselective hydrogenation for the concise synthesis of the originally assigned macrolactone core of (−)-lyngbouilloside, with easy adaptability to C10/C11 and C13 diastereomeric analogs.
Retrosynthetic analysis reveals a late-stage installation of the C16-C17 E-olefin and Lrhamnose-derived pyranoside. The macrolactone core 3 can be constructed by Boeckman acylketene cyclization 10 of β-keto ester 4, formed via a pivotal one-pot, sequential RCM/CM/chemoselective hydrogenative coupling of the phosphate triene (R,R)-5 with the advanced C8-C16 fragment 6, followed by Roskamp homologation and deprotection of the C13 tertiary carbinol. Triene (R,R)-5 is readily prepared in 2-steps via sequential tripodal coupling of the C 2 -symmetric anti-diene diol (R,R)-7 and allyl alcohol with POCl 3 or in one step utilizing phosphoramidite chemistry. 9a Fragment 6 is obtainable by Brown anticrotylation and Sharpless asymmetric epoxidation of commercially inexpensive geraniol (8) in a scalable 9-step route (Scheme 1). Initial synthetic studies focused on the construction of the C8-C16 fragment 6 from Sharpless asymmetric epoxidation 11 of geraniol (8) using (−)-DET, TBHP, Ti(O i Pr) 4 , followed by regioselective epoxide opening mediated by Red-Al, 12 and subsequent protection of the 1,3-diol moiety to afford the PMP acetal 9 as a 1:1 ratio of diastereomers in excellent yield (Scheme 2). Ozonolysis of compound 9, followed by in situ reductive workup, afforded alcohol 10 in 87% overall yield. Silylation of the primary alcohol 10 with TBSCl generated the corresponding silyl ether and subsequent regioselective opening of the PMP-acetal with DIBAL-H produced primary alcohol 9 in 89% yield. Parikh-Doering oxidation 13 of the resulting alcohol 11, followed by reagent-controlled enantioselective Brown anti-crotylation, 14 furnished desired homoallylic alcohol 12 in good yield. Silylation of homoallyl alcohol 12 afforded the required C8-C16 fragment 6 in 95% yield.
Construction of subunit 13 was achieved from triene (R,R)-5 via a one-pot, sequential RCM/CM/chemoselective hydrogenation with the C8-C16 fragment 6 as the CM partner (Scheme 3). Following the previously reported optimized conditions for RCM/CM/"H 2 ", 8c triene (R,R)-5 was first subjected to RCM reaction with the second generation HoveydaGrubbs catalyst (HG-II) 15 (6 mol %) in CH 2 Cl 2 (0.007 M), and upon completion, the CM partner 6 in DCE (0.1 M) was added. The reaction was continued at 90 °C with simultaneous evaporation of low boiling solvent from the previous reaction to reach optimal concentration (~ 0. With diol 14 in hand, silylation of both alcohols with TESOTf (2,6-lutidine, CH 2 Cl 2 ) generated the differentially protected subunit 15 in quantitative yield (Scheme 4). Oxidative cleavage of the terminal olefin in 15 using a modified Johnson-Lemieux protocol developed by Jin 17 and coworkers (OsO 4 , NaIO 4 , 2,6-lutidine), yielded the corresponding aldehyde which was immediately subjected to a two-carbon Roskamp homologation 18 with ethyl diazoacetate in the presence of SnCl 4 •5H 2 O to furnish β-keto ester 16 in 76% overall yield over the final two steps. Deprotection of the PMB ether by oxidative cleavage using DDQ produced the Boeckman cyclization precursor 4 in excellent yield. Pyrolysis of β-keto ester 4 in toluene under dilute conditions (0.0007 M) using a Dean-Stark condenser with azeotropic removal of EtOH afforded macrolactone 3 in excellent yield (90%) using Boeckman cyclization conditions previously reported by several in the context of complex macrolactonization. 5, 10 The mechanism of the high yielding Boeckman cyclization of β-keto ester 4 is worth noting and presumably proceeds as outlined in Scheme 5. 19 Thus, initial formation of acylketene C proceeds under thermal conditions from 4, with subsequent addition of an accessible hydroxyl group leading to enol-D and final tautomerization affording the β-keto macrolactone 3. Overall, this high yielding cyclization enables macrocyclization from the hindered C13 carbinol and circumvents the aforementioned issues noted by Cossy in their synthesis of lyngbouilloside aglycon. 5 In conclusion, we report a concise route to the originally assigned structure of lyngbouilloside macrolactone core 3 that is easily adaptable 20 to potential C10/C11 and C13 variants proposed by the revised structure of lyngbouilloside 1 reported by Cossy and coworkers, 5 as well as implied in the work of Fuwa in 2014 on the unambiguous determination of the closely related structure of lyngbyaloside B (2b). 7 Highlights of the synthesis include a phosphate tether-mediated, one-pot, sequential RCM/CM/ chemoselective hydrogenation reaction, Roskamp homologation, and a high yielding Boeckman acylketene cyclization. Overall, the synthesis is highly modular and will enable analog synthesis. Efforts aimed at completing the total synthesis as well as simplified analogs are in process and will be reported in due course.
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